Omron to Acquire Colin Medical

Adding new monitoring devices to its line, Omron Healthcare Co. Ltd. (Kyoto, Japan;), has announced it will acquire Colin Medical Technology Corp. (CMT, Komati, Japan, USA) from the Carlyle Group (Washington, DC, USA) in a transfer of stock. Further financial details were not disclosed.

Through this acquisition, Omron Healthcare will own CMT's medical devices, such as bio-information monitors, inpatient blood-pressure monitoring devices, and vascular screening devices, in addition to Omron's home healthcare products, including blood-pressure monitors and body fat analyzers. Omron Healthcare will be able to offer a wide variety of medical devices in hospitals and the home, and anticipates creating a new market by connecting medical workplaces and patient homes.

"Omron predicted the shift within the medical market from treatment to prevention,” said Mr. Hisao Sakuta, representative director and CEO of Omron Corp. Because Omron Healthcare has already achieved a high market share and because of the increasing competition caused by Asian low-cost manufacturers, the company seeks new business domains for continued growth. Omron plans to establish a new market for the monitoring of hardened arteries by combining CMT and Omron Healthcare's technology and devices. Also in its plans is a preventive-medicine-care support system utilizing a management program for life-style related diseases and medical devices.

"We believe this relationship will let us enter new business domains and expand our business, which we could not have successfully completed alone,” noted Yuzo Kambe, president and COO of CMT. "In addition, we will come closer to realizing CMT's mission of reducing clinical accidents to one out of every 100 and reducing the numbers of bedridden elderly people by half.”

>>
CMT >>


Related Links:
Omron Healthcare
Colin Medical Technology